The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors

The FDA-approved anti-DNA virus agent cidofovir (CDV) is being evaluated in phase II/III clinical trials for the treatment of human papillomavirus (HPV)-associated tumors. However, previous observations had shown that CDV also inhibits the growth of vascular tumors induced by fibroblast growth facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Liekens, Sandra, Noppen, Sam, Gijsbers, Sofie, Sienaert, Rebecca, Ronca, Roberto, Tobia, Chiara, Presta, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467104/
https://www.ncbi.nlm.nih.gov/pubmed/25609197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467104/
https://www.ncbi.nlm.nih.gov/pubmed/25609197

Ejemplares similares